1. Home
  2. DH vs OKYO Comparison

DH vs OKYO Comparison

Compare DH & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$0.70

Market Cap

90.9M

Sector

Technology

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.67

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DH
OKYO
Founded
2011
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.9M
81.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DH
OKYO
Price
$0.70
$1.67
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$3.08
$6.33
AVG Volume (30 Days)
210.4K
160.1K
Earning Date
05-07-2026
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
63.28
N/A
EPS
N/A
N/A
Revenue
$241,521,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$1.34
52 Week High
$4.70
$3.35

Technical Indicators

Market Signals
Indicator
DH
OKYO
Relative Strength Index (RSI) 43.45 57.47
Support Level $0.64 $1.45
Resistance Level $0.94 $1.72
Average True Range (ATR) 0.05 0.11
MACD -0.00 0.02
Stochastic Oscillator 22.47 79.26

Price Performance

Historical Comparison
DH
OKYO

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: